WEBINAR - August 20, 2025
Maximize Lead Gen ROI: A Step-By-Step Guide for Life Science Companies

Governor Abbott Announces NTxBio Facility In Plano

PLANO, Texas., May 15 /ntxbio.com/ — Governor Abbott announces NTxBio’s major expansion into Plano with a $31 million biomanufacturing facility creating over 170 jobs, supported by Texas Enterprise Fund investment to strengthen the state’s life sciences sector.

Oligo Factory Launches Low-Scale Oligo Synthesis Capability to Broaden Support for Therapeutic and Diagnostic Researchers and Developers

HOLLISTON, Mass., May 19, 2025 /Oligo Factory Communications/ — Oligo Factory launches new low-scale oligo synthesis capability, enabling researchers to order custom DNA and RNA oligonucleotides at volumes as low as 50 nmol while maintaining high quality and service standards. The company also introduces its FactorTx™ portfolio to support therapeutic development from discovery through clinical phases.

Sermonix and Regor Announce Strategic Collaboration to Optimize Regor’s Proprietary rCARD Platform for Identification of Novel Targets and Therapeutics

COLUMBUS, Ohio, and CAMBRIDGE, Mass., March 24 /PRNewswire/ — Sermonix Pharmaceuticals and Regor Therapeutics Group have entered a strategic collaboration. The partnership will utilize Regor’s rCARD™ platform to identify novel targets and therapeutics for metastatic breast cancer, aiming for treatments that balance efficacy with tolerability and quality of life.